[Thrombolytic treatment of peripheral arterial circulatory disorders with streptokinase].
The purpose of these investigations is to refer to the possibility of the reconstructive treatment of arterial obstructions by means of streptokinase. New application methods improved the chances of success of fibrinolysis. They run about 50%. The local application of smaller doses of streptokinase confines the contraindications to a certain extent. Obstruction in the pelvic area which are not older than three months and such ones in the femoropopliteal part up to 6 weeks are to be regarded as indication to the fibrinolysis. In the care of patients with arterial obstructive diseases importance should, therefore, be attached to the fact that thrombotic shifts should be recognized in time an the possibility of a fibrinolytic therapy is tested within the periods mentioned.
Altmann
E
E
Schmidt
P K
PK
Schwabe
W
W
Papsdorf
G
G
Schumann
I
I
Förster
H J
HJ
D000368:Aged; D000800:Angioplasty, Balloon; D001807:Blood Vessel Prosthesis; D003131:Combined Modality Therapy; D004617:Embolism / Q000188:drug therapy; D005260:Female; D006083:Graft Occlusion, Vascular / Q000188:drug therapy; D006801:Humans; D007511:Ischemia / Q000188:drug therapy; D007866:Leg / Q000098:blood supply*; D008297:Male; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy* / Q000601:surgery
D013300:Streptokinase
Thrombolytische Behandlung peripherer arterieller Durchblutungsstörungen mit Streptokinase.